Deals

Closeup of blue eye on black background
Biotech

Lilly buys cash-strapped Adverum for eye disease gene therapy

Just as Adverum’s cash reserves were running dry, Eli Lilly has swooped in to buy the biotech and its phase 3-stage eye disease gene therapy.
James Waldron Oct 24, 2025 9:25am
Glowing puzzle piece fitting into puzzle

Biogen pens $1B deal for Vanqua's preclinical C5aR1 antagonist

Oct 24, 2025 9:15am
Illustration connected puzzle pieces with the acronym MA

Ipsen inks €1B buyout of French biotech ImCheck

Oct 22, 2025 10:33am
gold coins and bars

Takeda strikes Innovent pact worth up to $11.4B

Oct 22, 2025 9:15am
puzzle pieces merger and acquisition business concept

Hologic to go private with $18.3B deal by Blackstone and TPG

Oct 22, 2025 8:45am
piggy bank surrounded by question marks

PE dealmaking, exit counts on the rise in Q3: PitchBook

Oct 20, 2025 5:05pm